Published in Proteomics Clin Appl on January 22, 2007
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer. Clin Chem (2007) 2.38
Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. J Proteome Res (2009) 2.33
Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias. Clin Chem (2007) 2.23
Urinary proteomics in diabetes and CKD. J Am Soc Nephrol (2008) 2.12
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics (2010) 1.90
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin Appl (2008) 1.57
Proteome-wide identification of proteins and their modifications with decreased ambiguities and improved false discovery rates using unique sequence tags. Anal Chem (2008) 1.26
Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies. Mol Cell Proteomics (2010) 1.21
Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments. Mass Spectrom Rev (2009) 1.19
High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine. Proteomics Clin Appl (2007) 1.17
Addressing the challenge of defining valid proteomic biomarkers and classifiers. BMC Bioinformatics (2010) 1.16
Biomarkers for prostate cancer. World J Urol (2007) 1.16
Evaluation of urinary biomarkers for coronary artery disease, diabetes, and diabetic kidney disease. Diabetes Technol Ther (2009) 1.08
Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers. PLoS One (2011) 1.07
Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research. Alzheimers Dement (2014) 1.06
Is the word 'biomarker' being properly used by proteomics research in neuroscience? Eur Arch Psychiatry Clin Neurosci (2010) 1.06
Challenges for biomarker discovery in body fluids using SELDI-TOF-MS. J Biomed Biotechnol (2009) 1.05
Integrated multi-level quality control for proteomic profiling studies using mass spectrometry. BMC Bioinformatics (2008) 1.04
Implementation of proteomic biomarkers: making it work. Eur J Clin Invest (2012) 1.00
Discovery and validation of urinary biomarkers for prostate cancer. Proteomics Clin Appl (2008) 1.00
Quality assessment for clinical proteomics. Clin Biochem (2012) 0.98
Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases. World J Urol (2007) 0.97
Sources of Urinary Proteins and their Analysis by Urinary Proteomics for the Detection of Biomarkers of Disease. Proteomics Clin Appl (2009) 0.97
Strategy for degradomic-peptidomic analysis of human blood plasma. J Proteome Res (2010) 0.95
Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression. Breast Cancer Res (2008) 0.92
The application of mass-spectrometry-based protein biomarker discovery to theragnostics. Br J Clin Pharmacol (2010) 0.91
Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand? Eur Arch Psychiatry Clin Neurosci (2011) 0.90
Applying proteomics to the diagnosis and treatment of ALS and related diseases. Muscle Nerve (2009) 0.89
Urine proteome analysis reflects atherosclerotic disease in an ApoE-/- mouse model and allows the discovery of new candidate biomarkers in mouse and human atherosclerosis. Mol Cell Proteomics (2012) 0.88
Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease. Pediatr Nephrol (2009) 0.87
Mass spectrometry based proteomics in urine biomarker discovery. World J Urol (2007) 0.86
Prediction of the clinical outcome in invasive candidiasis patients based on molecular fingerprints of five anti-Candida antibodies in serum. Mol Cell Proteomics (2010) 0.86
Automated diagnosis of LC-MS/MS performance. Bioinformatics (2009) 0.85
Proteomics and metabolomics in renal transplantation-quo vadis? Transpl Int (2012) 0.85
Personalized Proteomics: The Future of Precision Medicine. Proteomes (2016) 0.85
Towards proteome standards: the use of absolute quantitation in high-throughput biomarker discovery. J Proteomics (2010) 0.84
Identifying novel biomarkers through data mining-a realistic scenario? Proteomics Clin Appl (2015) 0.84
Perspectives on systems biology applications in diabetic kidney disease. J Cardiovasc Transl Res (2012) 0.84
Spatiotemporal proteomic analyses during pancreas cancer progression identifies serine/threonine stress kinase 4 (STK4) as a novel candidate biomarker for early stage disease. Mol Cell Proteomics (2014) 0.83
Current application of proteomics in biomarker discovery for inflammatory bowel disease. World J Gastrointest Pathophysiol (2016) 0.81
A method for identifying discriminative isoform-specific peptides for clinical proteomics application. BMC Genomics (2016) 0.81
Serum profiling by MALDI-TOF mass spectrometry as a diagnostic tool for domoic acid toxicosis in California sea lions. Proteome Sci (2012) 0.80
Classification-based comparison of pre-processing methods for interpretation of mass spectrometry generated clinical datasets. Proteome Sci (2009) 0.80
Nutrigenomics and personalized diets: What will they mean for food? Annu Rev Food Sci Technol (2011) 0.79
Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform. World J Urol (2008) 0.79
Two-dimensional electrophoretic comparison of metastatic and non-metastatic human breast tumors using in vitro cultured epithelial cells derived from the cancer tissues. BMC Cancer (2008) 0.79
Quantifying antibody binding on protein microarrays using microarray nonlinear calibration. Biotechniques (2013) 0.78
Effects of sample delivery on analyte capture in porous bead sensors. Lab Chip (2012) 0.78
Application of Proteomic Analysis to Renal Disease in the Clinic. Proteomics Clin Appl (2009) 0.76
Label-free quantitative urinary proteomics identifies the arginase pathway as a new player in congenital obstructive nephropathy. Mol Cell Proteomics (2014) 0.76
A capillary electrophoresis coupled to mass spectrometry pipeline for long term comparable assessment of the urinary metabolome. Sci Rep (2016) 0.75
An automated plasma protein fractionation design: high-throughput perspectives for proteomic analysis. BMC Res Notes (2012) 0.75
Application of multiple statistical tests to enhance mass spectrometry-based biomarker discovery. BMC Bioinformatics (2009) 0.75
Pain in the Blood? Envisioning Mechanism-Based Diagnoses and Biomarkers in Clinical Pain Medicine. Diagnostics (Basel) (2015) 0.75
Identification of differentially expressed splice variants by the proteogenomic pipeline Splicify. Mol Cell Proteomics (2017) 0.75
Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease. Clin Kidney J (2017) 0.75
The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res (2003) 52.80
The minimum information about a genome sequence (MIGS) specification. Nat Biotechnol (2008) 31.04
InterPro: the integrative protein signature database. Nucleic Acids Res (2008) 25.07
The InterPro Database, 2003 brings increased coverage and new features. Nucleic Acids Res (2003) 24.72
The Universal Protein Resource (UniProt). Nucleic Acids Res (2005) 23.66
The Universal Protein Resource (UniProt): an expanding universe of protein information. Nucleic Acids Res (2006) 22.70
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01
The Gene Ontology Annotation (GOA) Database: sharing knowledge in Uniprot with Gene Ontology. Nucleic Acids Res (2004) 18.75
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2013) 18.17
InterPro, progress and status in 2005. Nucleic Acids Res (2005) 17.53
Genome-wide association analysis identifies 20 loci that influence adult height. Nat Genet (2008) 16.92
The HUPO PSI's molecular interaction format--a community standard for the representation of protein interaction data. Nat Biotechnol (2004) 16.08
Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res (2008) 15.69
Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics (2009) 15.08
IntAct: an open source molecular interaction database. Nucleic Acids Res (2004) 15.02
The International Protein Index: an integrated database for proteomics experiments. Proteomics (2004) 14.67
InterPro in 2011: new developments in the family and domain prediction database. Nucleic Acids Res (2011) 13.45
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature (2009) 13.28
The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res (2012) 13.14
Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project. Nat Biotechnol (2008) 12.96
The Gene Ontology Annotation (GOA) project: implementation of GO in SWISS-PROT, TrEMBL, and InterPro. Genome Res (2003) 12.81
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet (2007) 12.62
New developments in the InterPro database. Nucleic Acids Res (2007) 12.49
Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44
Prepublication data sharing. Nature (2009) 12.24
UniProt archive. Bioinformatics (2004) 11.92
A common open representation of mass spectrometry data and its application to proteomics research. Nat Biotechnol (2004) 11.42
Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res (2010) 11.23
The minimum information about a proteomics experiment (MIAPE). Nat Biotechnol (2007) 10.24
The GOA database in 2009--an integrated Gene Ontology Annotation resource. Nucleic Acids Res (2008) 10.21
EMBL Nucleotide Sequence Database in 2006. Nucleic Acids Res (2006) 9.72
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
The Ontology Lookup Service, a lightweight cross-platform tool for controlled vocabulary queries. BMC Bioinformatics (2006) 8.68
The Reactome pathway knowledgebase. Nucleic Acids Res (2013) 8.56
Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet (2010) 8.55
Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med (2014) 8.36
The minimum information required for reporting a molecular interaction experiment (MIMIx). Nat Biotechnol (2007) 8.24
Broadening the horizon--level 2.5 of the HUPO-PSI format for molecular interactions. BMC Biol (2007) 8.03
PRIDE: the proteomics identifications database. Proteomics (2005) 7.52
The IntAct molecular interaction database in 2012. Nucleic Acids Res (2011) 7.49
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int (2009) 7.45
Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet (2008) 7.33
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int (2009) 7.19
The EMBL Nucleotide Sequence Database. Nucleic Acids Res (2005) 7.18
Integrative annotation of 21,037 human genes validated by full-length cDNA clones. PLoS Biol (2004) 7.17
Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res (2002) 7.11
Calling on a million minds for community annotation in WikiProteins. Genome Biol (2008) 7.11
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S A (2013) 6.88
The EMBL Nucleotide Sequence Database. Nucleic Acids Res (2004) 6.72
A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci U S A (2005) 6.61
An evaluation of GO annotation retrieval for BioCreAtIvE and GOA. BMC Bioinformatics (2005) 6.58
Integrating biological data--the Distributed Annotation System. BMC Bioinformatics (2008) 6.56
The EBI SRS server-new features. Bioinformatics (2002) 6.38
Progress and prospects in rat genetics: a community view. Nat Genet (2008) 6.01
Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet (2009) 5.81
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet (2011) 5.73
A guide to the Proteomics Identifications Database proteomics data repository. Proteomics (2009) 5.63
The UniProt-GO Annotation database in 2011. Nucleic Acids Res (2011) 5.19
EMBL Nucleotide Sequence Database: developments in 2005. Nucleic Acids Res (2006) 5.13
PSICQUIC and PSISCORE: accessing and scoring molecular interactions. Nat Methods (2011) 5.01
Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet (2009) 4.97
High-quality protein knowledge resource: SWISS-PROT and TrEMBL. Brief Bioinform (2002) 4.95
UniProtJAPI: a remote API for accessing UniProt data. Bioinformatics (2008) 4.88
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens (2009) 4.87
Regulation and role of Raf-1/B-Raf heterodimerization. Mol Cell Biol (2006) 4.84
mzML--a community standard for mass spectrometry data. Mol Cell Proteomics (2010) 4.81
The Ontology Lookup Service: more data and better tools for controlled vocabulary queries. Nucleic Acids Res (2008) 4.73
Toward interoperable bioscience data. Nat Genet (2012) 4.72
IntEnz, the integrated relational enzyme database. Nucleic Acids Res (2004) 4.65
2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens (2007) 4.59
The Proteomics Identifications database: 2010 update. Nucleic Acids Res (2009) 4.47
PRIDE: new developments and new datasets. Nucleic Acids Res (2007) 4.42
The MIntAct project--IntAct as a common curation platform for 11 molecular interaction databases. Nucleic Acids Res (2013) 4.39
The Rice Annotation Project Database (RAP-DB): 2008 update. Nucleic Acids Res (2007) 4.23
Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21
PRIDE: a public repository of protein and peptide identifications for the proteomics community. Nucleic Acids Res (2006) 4.19
Integr8 and Genome Reviews: integrated views of complete genomes and proteomes. Nucleic Acids Res (2005) 4.15
The Protein Identifier Cross-Referencing (PICR) service: reconciling protein identifiers across multiple source databases. BMC Bioinformatics (2007) 3.97
Evidence standards in experimental and inferential INSDC Third Party Annotation data. OMICS (2006) 3.97
Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy. Kidney Int (2003) 3.95
The implications of alternative splicing in the ENCODE protein complement. Proc Natl Acad Sci U S A (2007) 3.93
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study. Lancet Oncol (2009) 3.89
Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat Genet (2013) 3.87